Cargando…

Utilization of Behavioral Medicine Services to Refine Medical Diagnostic Formulation in the Face of Uncertain Symptom Presentation

In the ever expanding realm of cancer care, the psychosocial impact of disease and medical treatments has been garnering increased attention. To address these needs, the integration of behavioral medicine services into inpatient and outpatient medical settings has added a unique resource available t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, David A., Markman, Elisabeth S., McMahon, Cori E., Markman, Maurie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043164/ https://www.ncbi.nlm.nih.gov/pubmed/27721774 http://dx.doi.org/10.1159/000447553

Ejemplares similares

Update on the utility of prognostic biomarkers in ovarian cancer
por: Markman, Maurie
Publicado: (2009)

A Case Report Demonstrating Unambiguous Clinical Utility of Pet/CT Scanning in Recurrent Ovarian Cancer
por: Mutch, David, et al.
Publicado: (2009)

Cardio-Oncology: mechanisms of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2018)

Cardio-oncology: management of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2019)

Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer
por: Markman, Maurie
Publicado: (2011)

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
por: Markman, Maurie
Publicado: (2009)

Involvement of Bone in Epithelial Ovarian Cancer: Case Report of an Uncommon Late Metastatic Event
por: Markman, Maurie
Publicado: (2011)

Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report
por: Markman, Maurie
Publicado: (2010)

Recent studies that influence the chemotherapeutic paradigm in the management of advanced ovarian cancer
por: Markman, Maurie
Publicado: (2010)

Is It Time to Inform This Patient that Further Antineoplastic Drug Therapy Will Not Be of Clinical Value?
por: Markman, Maurie
Publicado: (2010)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: Where Do We Go From Here?
por: Markman, Maurie
Publicado: (2016)

New developments in the anti-neoplastic drug management of ovarian cancer
por: Markman, Maurie
Publicado: (2013)

Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
por: Markman, Maurie
Publicado: (2018)

Synchronous Presentation of a Primary Iliac Lymph Node Plasmacytoma and a Prostate Adenocarcinoma
por: Klimant, Eiko, et al.
Publicado: (2011)

Case of Ovarian Cancer in a Woman with Undiagnosed Graves’ Disease: A Case Report and Review of the Literature
por: Markman, Timothy M., et al.
Publicado: (2017)

An Example of Ovarian Cancer as a ‘Chronic Disease Process' – 11-Year Survival with Multiple Treatments for Recurrent and Progressive Disease
por: Markman, Maurie, et al.
Publicado: (2008)

A Case Report of Hodgkin's Lymphoma in a Patient with Carcinosarcoma of the Bladder
por: Perre, Anthony, et al.
Publicado: (2011)

Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
por: Anand, Rachna, et al.
Publicado: (2011)

Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
por: Chen, Jian, et al.
Publicado: (2009)

Early Onset of Platinum Hypersensitivity in a Dentist: A Case Report
por: Markman, Maurie, et al.
Publicado: (2010)

Hypersensitivity following Retreatment with Carboplatin a Decade after Completion of Primary Platinum-Based Chemotherapy
por: Williams, Laura, et al.
Publicado: (2009)

Management of Two Cases of Recurrent Anal Carcinoma
por: Klimant, Eiko, et al.
Publicado: (2013)

The relationship between patient satisfaction with service quality and survival in pancreatic cancer
por: Gupta, Digant, et al.
Publicado: (2012)

An Experience with Managing Cancer Patients Reportedly Previously Informed of the Absence of Additional Available Antineoplastic Therapeutic Options
por: River, George, et al.
Publicado: (2014)

Metastatic Breast Cancer with Extensive Osseous Metastasis Presenting with Symptomatic Immune Thrombocytopenic Purpura and Anemia: A Case Report and Review of the Literature
por: Niu, Jiaxin, et al.
Publicado: (2015)

Cyclophosphamide-Induced Severe Acute Hyponatremic Encephalopathy in Patients with Breast Cancer: Report of Two Cases
por: Baker, Michelle, et al.
Publicado: (2014)

Pegylated Liposomal Doxorubicin-Induced Acute Transient Encephalopathy in a Patient with Breast Cancer: A Case Report
por: Baker, Michelle, et al.
Publicado: (2014)

A Case Report Demonstrating the Potential Clinical Relevance of Liquid Tumor Biopsies in Lung Cancer
por: Suppiah, Revathi, et al.
Publicado: (2016)

Clinically Meaningful Responses to Sequential Gemcitabine-Based Chemotherapy Regimens in a Patient with Metastatic Pancreatic Cancer
por: Klimant, Eiko, et al.
Publicado: (2013)

Superficial Hyperthermia plus External Beam Radiation in the Palliation of Locally Progressive Chemoradiation-Resistant Breast Cancer
por: Heese, Curt, et al.
Publicado: (2012)

Longitudinal health-related quality of life assessment: implications for prognosis in ovarian cancer
por: Gupta, Digant, et al.
Publicado: (2013)

Treatment of Leptomeningeal Metastases in a Patient with Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation
por: Niu, Hardy, et al.
Publicado: (2017)

Comprehensive genomic profiling (CGP) of ovarian clear cell carcinomas (OCCC) identifies clinically relevant genomic alterations (CRGA) and targeted therapy options
por: Elvin, Julia A., et al.
Publicado: (2017)

Laparoscopic Splenectomy in Colorectal Cancer Patients with Chemotherapy-Associated Thrombocytopenia due to Hypersplenism
por: Litvak, David A., et al.
Publicado: (2012)

Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
por: Park, Peter Y., et al.
Publicado: (2015)

Role of nutritional status in predicting quality of life outcomes in cancer – a systematic review of the epidemiological literature
por: Lis, Christopher G, et al.
Publicado: (2012)

Can Quality of Life Assessments Differentiate Heterogeneous Cancer Patients?
por: McCabe, Ryan M., et al.
Publicado: (2014)

Masks of the spirit : Image and metaphor in mesoamerica
por: Markman, Peter T.
Publicado: (1989)

Further evidence of clinical benefit associated with participation in phase I oncology trials
por: Markman, M
Publicado: (2008)

Taxol: an important new drug in the management of epithelial ovarian cancer.
por: Markman, M.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_it9uk4rhs2v2n8p6h4thcliltu